Literature DB >> 14690616

The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets.

Steven Bodovitz1, Thomas Joos.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14690616     DOI： 10.1016/j.tibtech.2003.10.013

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN： 0167-7799            Impact factor:   19.536


× No keyword cloud information.
  4 in total

Review 1.  Metabolic engineering in the -omics era: elucidating and modulating regulatory networks.

Authors:  Goutham N Vemuri; Aristos A Aristidou
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

Review 2.  Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry.

Authors:  Jose L Luque-Garcia; Thomas A Neubert
Journal:  J Chromatogr A       Date:  2006-12-12       Impact factor: 4.759

3.  Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.

Authors:  Adriana Aguilar-Mahecha; Christiane Cantin; Maureen O'Connor-McCourt; Andre Nantel; Mark Basik
Journal:  Proteome Sci       Date:  2009-04-06       Impact factor: 2.480

4.  State of the art in tumor antigen and biomarker discovery.

Authors:  Klervi Even-Desrumeaux; Daniel Baty; Patrick Chames
Journal:  Cancers (Basel)       Date:  2011-06-09       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.